These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11244720)

  • 1. [Structure and function of the CAD domains of caspase-activated DNase(CAD) and inhibitor of CAD].
    Otomo T; Yamazaki T; Uegaki K; Sakahira H; Nagata S
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(3):233-9. PubMed ID: 11244720
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor.
    Uegaki K; Otomo T; Sakahira H; Shimizu M; Yumoto N; Kyogoku Y; Nagata S; Yamazaki T
    J Mol Biol; 2000 Apr; 297(5):1121-8. PubMed ID: 10764577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the heterodimeric complex between CAD domains of CAD and ICAD.
    Otomo T; Sakahira H; Uegaki K; Nagata S; Yamazaki T
    Nat Struct Biol; 2000 Aug; 7(8):658-62. PubMed ID: 10932250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DFF40/CAD endonuclease and its role in apoptosis.
    Widłak P
    Acta Biochim Pol; 2000; 47(4):1037-44. PubMed ID: 11996094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD.
    Sakahira H; Takemura Y; Nagata S
    Arch Biochem Biophys; 2001 Apr; 388(1):91-9. PubMed ID: 11361146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of chromosomal DNA during apoptosis.
    Nagata S; Nagase H; Kawane K; Mukae N; Fukuyama H
    Cell Death Differ; 2003 Jan; 10(1):108-16. PubMed ID: 12655299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large complex formation of the inhibitor of caspase-activated DNase.
    Kanouchi H; Nishizaki H; Minatogawa Y; Toné S
    Apoptosis; 2005 May; 10(3):651-6. PubMed ID: 15909126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid fibril formation by the CAD domain of caspase-activated DNase.
    Uegaki K; Nakamura T; Yamamoto H; Kobayashi A; Odahara T; Harata K; Hagihara Y; Ueyama N; Yamazaki T; Yumoto N
    Biopolymers; 2005 Sep; 79(1):39-47. PubMed ID: 15940676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAD-ICAD complex structure derived from saturation transfer experiment and simulated annealing without using pairwise NOE information.
    Matsuda T; Nakajima N; Yamazaki T; Nakamura H
    J Mol Recognit; 2004; 17(1):41-50. PubMed ID: 14872536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein.
    Ben-Yehudah A; Aqeilan R; Robashkevich D; Lorberboum-Galski H
    Clin Cancer Res; 2003 Mar; 9(3):1179-90. PubMed ID: 12631624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin activates caspase-3 and downregulates CAD during erythroid differentiation in TF-1 cells - a protection mechanism against DNA fragmentation.
    Lui JC; Kong SK
    FEBS Lett; 2006 Apr; 580(8):1965-70. PubMed ID: 16529748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique role of the DNA fragmentation factor in maintaining genomic stability.
    Yan B; Wang H; Peng Y; Hu Y; Wang H; Zhang X; Chen Q; Bedford JS; Dewhirst MW; Li CY
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1504-9. PubMed ID: 16432220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of ICAD-derived peptides capable of inhibiting caspase-activated DNase.
    Kutscher D; Pingoud A; Jeltsch A; Meiss G
    FEBS J; 2012 Aug; 279(16):2917-28. PubMed ID: 22727028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the region responsible for fibril formation in the CAD domain of caspase-activated DNase.
    Nakamura T; Kobayashi A; Hagihara Y; Takai T; Mine S; Yamazaki T; Yumoto N; Uegaki K
    J Biochem; 2005 Dec; 138(6):815-9. PubMed ID: 16428311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic DNA fragmentation factor maintains chromosome stability in a P53-independent manner.
    Yan B; Wang H; Wang H; Zhuo D; Li F; Kon T; Dewhirst M; Li CY
    Oncogene; 2006 Aug; 25(39):5370-6. PubMed ID: 16619042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific expression of DNasegamma during B-cell development and its role in B-cell receptor-mediated apoptosis in WEHI-231 cells.
    Shiokawa D; Shika Y; Araki S; Sunaga S; Mizuta R; Kitamura D; Tanuma S
    Cell Death Differ; 2007 May; 14(5):992-1000. PubMed ID: 17218958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of apoptotic nuclease caspase-activated DNase in etoposide-induced treatment-related acute myelogenous leukemia.
    Hars ES; Lyu YL; Lin CP; Liu LF
    Cancer Res; 2006 Sep; 66(18):8975-9. PubMed ID: 16982737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutually regulated expression of caspase-activated DNase and its inhibitor for apoptotic DNA fragmentation.
    Nagase H; Fukuyama H; Tanaka M; Kawane K; Nagata S
    Cell Death Differ; 2003 Jan; 10(1):142-3. PubMed ID: 12655303
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific chaperone-like activity of inhibitor of caspase-activated DNase for caspase-activated DNase.
    Sakahira H; Iwamatsu A; Nagata S
    J Biol Chem; 2000 Mar; 275(11):8091-6. PubMed ID: 10713130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased skin carcinogenesis in caspase-activated DNase knockout mice.
    Yan B; Wang H; Xie D; Wakamatsu N; Anscher MS; Dewhirst MW; Mitchel RE; Chen BJ; Li CY
    Carcinogenesis; 2009 Oct; 30(10):1776-80. PubMed ID: 19541853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.